Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The inflamed liver in chronic hepatitis B virus (HBV) infection (CHB) is characterized by a large influx of non–virus-specific CD8 T cells. Little is known about the functional capacity of these lymphocytes, which could provide insights into mechanisms of failure of viral control and liver damage in this setting. We compared the effector function of total circulating and intrahepatic CD8 T cells in CHB patients and healthy donors. We demonstrated that CD8 T cells from CHB patients, regardless of their antigen specificity, were impaired in their ability to produce interleukin-2 and proliferate upon TCR-dependent stimulation. In contrast, these CD8 T cells had preserved production of the proinflammatory cytokines interferon-γ and tumor necrosis factor-α. This aberrant functional profile was partially attributable to down-regulation of the proximal T cell receptor signaling molecule CD3ζ, and could be corrected in vitro by transfection of CD3ζ or replenishment of the amino acid arginine required for its expression. We provide evidence for depletion of arginine in the inflamed hepatic microenvironment as a potential mechanism for these defects in global CD8 T cell signaling and function. These data imply that polarized CD8 T cells within the HBV-infected liver may impede proliferative antiviral effector function, while contributing to the proinflammatory cytokine environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. CD3ζ is down-regulated in both peripheral and intrahepatic CD8 from patients with chronic HBV. PBMCs or intrahepatic lymphocytes isolated from biopsy tissue were surface stained for CD3ε and CD8, fixed, permeabilized, and stained for intracellular CD3ζ or its isotype. A tight lymphocyte gate and secondary gate over CD3ε+CD8 cells has been applied. A marker was applied at the edge of the isotype control (solid black line) and the proportion of CD8 to the right of this line represented the CD3ζ+ fraction. (a) Representative flow cytometric histogram illustrating CD3ζ expression (as a percentage and as mean fluorescence intensity [MFI]) for a chronic HBV-infected patient with high viral load (>106 IU/ml; dashed line) and a healthy control (gray). (b) CD3ζ levels, shown as both MFI and percentage of CD3ζ+ in the total CD8 are shown against viral load (top), and percentage values are further broken down by HBeAg status and ALT (bottom). (c) Histogram to illustrate differential expression of CD3ζ by peripheral (dark gray) and intrahepatic (light gray) CD8 from a CHB donor (dotted line, isotype). (d) The difference in CD3ζ expression between intrahepatic and peripheral CD8 is plotted for each patient with HBV/non-HBV–related liver disease.](https://figures.cochat.ai/paper-figures/7ff43f33481548d4a97e76a0dcd07fd0/functional-skewing-of-the-global-cd8-t-cell-population-in-chronic-hepatitis-b-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Phenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., & Chisari, F. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.68-76.2003 · Cited by 979
L-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007) · Blood · doi:10.1182/blood-2006-06-031856 · Cited by 926
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Self-citation
Research works printed but not linked: 3
- 1993, Cancer Res., 53, 5610
- 1991, Transplant. Proc., 23, 1436
- 1995, Hepatology., 21, 1585
Cited by
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805
“Hepatic expression of arginase and indoleamine 2,3-dioxygenase (IDO”
BackgroundArginase: an emerging key player in the mammalian immune system
Munder, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00291.x · Cited by 694
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Zoulim, F., & Locarnini, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.063 · Cited by 706
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donne, R., & Lujambio, A. (2023) · Hepatology · doi:10.1002/hep.32740 · Cited by 631
Therapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Self-citationLiving in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
“Enzymes responsible for the catabolism of these amino acids are released by damaged hepatocytes and other intrahepatic populations and are induced in HBV and HCV infection”
BackgroundSelf-citationA global scientific strategy to cure hepatitis B
Revill, P. A., Chisari, F. V., Block, J. M., Dandri, M., Gehring, A. J., Guo, H., Hu, J., Kramvis, A., Lampertico, P., Janssen, H. L. A., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30119-0 · Cited by 508
Self-citationFisicaro, P., Valdatta, C., Massari, M., Loggi, E., Biasini, E., Sacchelli, L., Cavallo, M. C., Silini, E. M., Andreone, P., Missale, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.052 · Cited by 488
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
“Arginine-deprived T cells downregulate the CD3z signaling molecule with subsequent TCRsignaling dysfunction [135].”
Self-citationBertoletti, A., & Ferrari, C. (2012) · Gut · doi:10.1136/gutjnl-2011-301073 · Cited by 477
“Interestingly, addition of L-arginine can restore CD3z expression and can improve T cell function.(69) Since L-arginine depletion due to increased arginase release is more pronounced during liver inflammation,(68) the metabolic conditions of the liver microenvironment can contribute to further modulate the already alt…”
BackgroundSelf-citationPathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?
Akbar, A. N., & Henson, S. M. (2011) · Nature Reviews Immunology · doi:10.1038/nri2959 · Cited by 474
“and during chronic infections, which are associated with the accumulation of large numbers of CD27 − CD28 − T cell”
BackgroundSelf-citationMetabolic and epigenetic regulation of T-cell exhaustion
Franco, F., Jaccard, A., Romero, P., Yu, Y.-R., & Ho, P.-C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00280-9 · Cited by 455
T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
Ye, B., Liu, X., Li, X., Kong, H., Tian, L., & Chen, Y. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.42 · Cited by 391
“Functional Change and Potential Mechanism of CD8+ T-cell Exhaustion in HBV Infection The HBV-specific CD8+ T cells exert their ability of viral clearance mainly by the production of anti-viral cytokines such as IFN-α/γ and granzyme/perforin.69 Aberrant functional profile was discovered in exhausted CD8+ T cells from C…”
BackgroundInfluentialTemporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection
Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N., Lascar, R. M., Brown, D., Gilson, R. J., Tedder, R. J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.054 · Cited by 362
Self-citationIL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A., Blair, P., Dusheiko, G., Gill, U., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103139 · Cited by 339
“This is in line with our previous finding that CD8 T cells are functionally impaired in CHB, regardless of their Ag specificity (22).”
ResultSelf-citationPresent and future therapies of hepatitis B: From discovery to cure
Liang, T. J., Block, T. M., McMahon, B. J., Ghany, M. G., Urban, S., Guo, J., Locarnini, S., Zoulim, F., Chang, K., & Lok, A. S. (2015) · Hepatology · doi:10.1002/hep.28025 · Cited by 317
Schurich, A., Khanna, P., Lopes, R. A., Han, K. J., Peppa, D., Micco, L., Nebbia, G., Kennedy, P. T. F., Geretti, A.-M., Dusheiko, G., et al. (2011) · Hepatology · doi:10.1002/hep.24249 · Cited by 307
“CHB VL>2000 IU/ml 51 27 38 (23-67) 700,000 (2000-163x10(6)) 57 (15-261) 28”
Self-citationBengsch, B., Martin, B., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.005 · Cited by 284
“It is likely that several factors contribute to HBV-specific CD8+ T cell dysfunction in chronic HBV infection, including the action of regulatory T cells, depletion of arginine in the inflamed liver microenvironment, causing reduced T cell receptor signalling, release of immunoregulatory cytokines, enhanced T cell apo…”
BackgroundSenescence of T Lymphocytes: Implications for Enhancing Human Immunity
Akbar, A. N., Henson, S. M., & Lanna, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.002 · Cited by 285
“An important observation is that T cells within both CD4 and CD8 compartments that have senescent characteristics increase during ageing [18, 31-36] and are therefore likely to have an impact on altered immune function in older individuals.”
BackgroundSelf-citationMetabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
Pallett, L. J., Gill, U. S., Quaglia, A., Sinclair, L. V., Jover-Cobos, M., Schurich, A., Singh, K. P., Thomas, N., Das, A., Chen, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3856 · Cited by 279
Self-citationHow to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
Wong, G. L. H., Gane, E., & Lok, A. S. F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.024 · Cited by 272
Hepatitis B Virus–Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Park, J.-J., Wong, D. K., Wahed, A. S., Lee, W. M., Feld, J. J., Terrault, N., Khalili, M., Sterling, R. K., Kowdley, K. V., Bzowej, N., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.050 · Cited by 249
Gehring, A. J., Xue, S.-A., Ho, Z. Z., Teoh, D., Ruedl, C., Chia, A., Koh, S., Lim, S. G., Maini, M. K., Stauss, H., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.025 · Cited by 217
“108 Journal of Hepatology 201 Notably, the tolerogenicmechanisms implicated in global T cell exhaustion/deletion in chronicHBVpatients did not carry over to T cells expressing exogenous TCRs in vitro [18–21].”
BackgroundResultSelf-citationHuang, L.-R., Wohlleber, D., Reisinger, F., Jenne, C. N., Cheng, R.-L., Abdullah, Z., Schildberg, F. A., Odenthal, M., Dienes, H.-P., van Rooijen, N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2573 · Cited by 216
Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection
Knolle, P. A., & Thimme, R. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.036 · Cited by 206
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook
Kramvis, A., Chang, K.-M., Dandri, M., Farci, P., Glebe, D., Hu, J., Janssen, H. L. A., Lau, D. T. Y., Penicaud, C., Pollicino, T., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00649-z · Cited by 185
Self-citationFerrari, C. (2015) · Liver International · doi:10.1111/liv.12749 · Cited by 196
“In addition to dysregulation of costimulatory pathways (61), impairment of TCR signalling by CD3f -chain down-regulation (62) and enhanced T-cell apoptosis caused by bim up-regulation (63) have also been proposed to explain how persistent exposure to high antigen concentrations and persistent inflammation can alter th…”
BackgroundLe Bert, N., Gill, U. S., Hong, M., Kunasegaran, K., Tan, D. Z. M., Ahmad, R., Cheng, Y., Dutertre, C.-A., Heinecke, A., Rivino, L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.019 · Cited by 193
Self-citationHepatitis B virus persistence and reactivation
Shi, Y., & Zheng, M. (2020) · BMJ · doi:10.1136/bmj.m2200 · Cited by 190
The impact of differential antiviral immunity in children and adults
Prendergast, A. J., Klenerman, P., & Goulder, P. J. R. (2012) · Nature Reviews Immunology · doi:10.1038/nri3277 · Cited by 188
Schurich, A., Pallett, L. J., Lubowiecki, M., Singh, H. D., Gill, U. S., Kennedy, P. T., Nastouli, E., Tanwar, S., Rosenberg, W., & Maini, M. K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003208 · Cited by 186
“In accordance with previously published work [19] and in line with the hierarchical loss of effector function characteristic of exhaustion [20], IL-2 production by HBV-specific T cells was rarely detected and was not recovered upon stimulation with IL-12 (Figure 4c).”
ResultSelf-citationFisicaro, P., Barili, V., Rossi, M., Montali, I., Vecchi, A., Acerbi, G., Laccabue, D., Zecca, A., Penna, A., Missale, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00849 · Cited by 160
“In HBVinfected patients the latter mechanism was demonstrated both in acutely and in chronically infected subjects and could be corrected in vitro by T cell transfection of CD3ζ or replenishment of the amino acid arginine required for its expression (19, 55).”
BackgroundLi, F., Wei, H., Wei, H., Gao, Y., Xu, L., Yin, W., Sun, R., & Tian, Z. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.039 · Cited by 164
Zhang, Z., Zhang, S., Zou, Z., Shi, J., Zhao, J., Fan, R., Qin, E., Li, B., Li, Z., Xu, X., et al. (2011) · Hepatology · doi:10.1002/hep.23977 · Cited by 157
“Generally, HBV-specific T cells were believed to play important roles in inducing hepatocellular damage during chronic HBV infection(2,3); however, recent studies have shown that these cells often display functional impairment, such as T cell exhaustion by up-regulation of programmed death 1,(4,5) T cell attrition thr…”
BackgroundImmunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
Pardee, A. D., & Butterfield, L. H. (2012) · OncoImmunology · doi:10.4161/onci.1.1.18344 · Cited by 160
“Dysfunctional T cell responses to both virus-specific and unrelated antigens, characterized by impaired proliferation and IL-2 production, are also observed in chronic HBV-infected patients.(16) Furthermore, the frequencies of intrahepatic Treg in these patients correlates with viral load, suggesting that Treg accumul…”
BackgroundHenson, S. M., Macaulay, R., Riddell, N. E., Nunn, C. J., & Akbar, A. N. (2015) · European Journal of Immunology · doi:10.1002/eji.201445312 · Cited by 146
Self-citationImmune Response in Hepatitis B Virus Infection
Tan, A. T., Koh, S., & Bertoletti, A. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021428 · Cited by 156
“By depleting the essential amino acid L-arginine, arginase contributes to the down-regulation of the CD3z chain on T cells (Das et al. 2008).”
BackgroundInfluentialSelf-citationHepatitis B virus resistance to antiviral drugs: where are we going?
Zoulim, F. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02399.x · Cited by 147
Hoogeveen, R. C., Robidoux, M. P., Schwarz, T., Heydmann, L., Cheney, J. A., Kvistad, D., Aneja, J., Melgaço, J. G., Fernandes, C. A., Chung, R. T., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316644 · Cited by 141
Liver biopsy findings in chronic hepatitis B #
Mani, H., & Kleiner, D. E. (2009) · Hepatology · doi:10.1002/hep.22930 · Cited by 130
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad
Ghany, M. G., Feld, J. J., Chang, K., Chan, H. L., Lok, A. S.-F., Visvanathan, K., & Janssen, H. L. A. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30344-9 · Cited by 133
The molecular basis of the failed immune response in chronic HBV: Therapeutic implications
Maini, M. K., & Schurich, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.017 · Cited by 129
Self-citationImmunotherapy for Chronic Hepatitis B Virus Infection
Bertoletti, A., & Bert, N. L. (2018) · Gut and Liver · doi:10.5009/gnl17233 · Cited by 110
Self-citationThe Host–pathogen Interaction during HBV Infection: Immunological Controversies
Bertoletti, A., Maini, M. K., & Ferrari, C. I. (2010) · Antiviral Therapy · doi:10.3851/imp1620 · Cited by 121
Self-citationThe Role of Natural Killer Cells and CD8+ T Cells in Hepatitis B Virus Infection
Schuch, A., Hoh, A., & Thimme, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00258 · Cited by 118
“It has also been reported that increased intrahepatic arginase levels (67, 107) and hence the lack of arginine lead to a functional silencing of CD8+ T cells due to the downregulation of the CD3ζ-chain (108).”
BackgroundKong, X., Sun, R., Chen, Y., Wei, H., & Tian, Z. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303432 · Cited by 114
“Enhanced Arg-1 expression has been ob- served in acute and chronic HBV patients, and it has been further shown to inhibit T cell activation by consuming arginine, leading to downregulation of the TCR signaling molecule CD3z (30, 31).”
BackgroundMartin, P., Dubois, C., Jacquier, E., Dion, S., Bourgine, M., Godon, O., Kratzer, R., Lélu, K., Evlachev, A., Méritet, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308041 · Cited by 107
Wang, S., Zhang, X., Ju, Y., Zhao, B. L., Yan, X., Hu, J., Shi, L., Yang, L., Ma, Z., Chen, L., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202100 · Cited by 105
Thimme, R., & Dandri, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.007 · Cited by 106
“In this regard, various studies have shown the potential capacity of HBV to suppress innate immunity [2–5] and high levels of viral antigens (HBeAg and HBsAg) have been linked to T-cell exhaustion in chronically HBV-infected individuals [6,7].”
BackgroundAliabadi, E., Urbanek‐Quaing, M., Maasoumy, B., Bremer, B., Graßhoff, M., Li, Y., Niehaus, C., Wedemeyer, H. H., Kraft, A. R. M., & Cornberg, M. (2021) · Gut · doi:10.1136/gutjnl-2021-324646 · Cited by 103
“36 However, ALT levels in our cohort were elevated only in a minority of patients and did not show a correlation with T cell responses.”
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection
Gehring, A. J., Haniffa, M. A., Kennedy, P. T. F., Ho, Z. Z., Boni, C., Shin, A., Banu, N., Chia, A., Lim, S. G., Ferrari, C. I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66043 · Cited by 100
“After years of exposure to high levels of viral antigen, T cells either display an exhausted phenotype (23, 24, 41, 42) or are deleted (22, 43).”
Self-citationMaini, M. K., & Pallett, L. J. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30007-4 · Cited by 113
Self-citationLi, X., Lu, Q., Chen, W., Xu, W. B., Liu, R., Zhang, S.-F., Du, J., Li, H., Yao, K., Zhai, D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4162 · Cited by 100
Zoulim, F., Fournier, C., Habersetzer, F., Sprinzl, M. F., Pol, S., Coffin, C. S., Leroy, V., Ma, M. M., Wedemeyer, H. H., Lohse, A. W., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1651141 · Cited by 97
Positive and Negative Regulation of Cellular Immune Responses in Physiologic Conditions and Diseases
Viganó, S., Perreau, M., Pantaleo, G., & Harari, A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/485781 · Cited by 117
“Multiple studies have confirmed that high expression levels of PD-1 are associated with functional anergy and increased susceptibility to apoptosis [88, 97] in the context of human virus infections such as HIV [88, 91, 97–99], HCV [90, 91], HBV [89, 100], and also established tumors [101–105].”
BackgroundInfluentialWatanabe, T., Bertoletti, A., & Tanoto, T. A. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01313.x · Cited by 94
Self-citationImmune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
Kotsari, M., Dimopoulou, V., Koskinas, J. S., & Armakolas, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411471 · Cited by 102
Roadmap to functional cure of chronic hepatitis B: An expert consensus
Ning, Q., Wu, D., Wang, G., Ren, H., Gao, Z., Hu, P., Han, M., Wang, Y., Zhang, W., Lu, F., et al. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13126 · Cited by 101
“Persistent exposure to high antigen concentrations and the tolerizing microenvironment within the liver might contribute to functional exhaustion or deletion of HBV-specific T-cells [22-24].”
BackgroundAllweiss, L., Volz, T., Lütgehetmann, M., Giersch, K., Bornscheuer, T., Lohse, A. W., Petersen, J., Ma, H., Klumpp, K., Fletcher, S. P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.021 · Cited by 91
Therapeutic vaccination for treatment of chronic hepatitis B
Cargill, T. N., & Barnes, E. J. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13614 · Cited by 90
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy
Su, T., Yang, H., Tseng, T., Liou, J., Liu, C., Chen, C.-L., Chen, P., Chen, D.-S., Liu, C.-J., & Kao, J. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix690 · Cited by 85
Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence
Swadling, L., Pallett, L. J., Diniz, M. O., Baker, J. M., Amin, O. E., Stegmann, K. A., Burton, A. R., Schmidt, N. M., Jeffery-Smith, A., Zakeri, N., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.050 · Cited by 76
“…also unique in that most of its blood supply is venous and, therefore, relatively low in oxygen and flow rate when compared with arterial blood (reviewed in Carreau et al., 2011), and key T cell metabolites may be depleted within the liver microvasculature (Pallett et al., 2015; Das et al., 2008).”
BackgroundSelf-citationHBV-Specific CD8+ T-Cell Tolerance in the Liver
Baudi, I., Kawashima, K., & Isogawa, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.721975 · Cited by 84
Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells
Sandalova, E., Laccabue, D., Boni, C., Watanabe, T., Tan, A. T., Zong, H. Z., Ferrari, C. I., & Bertoletti, A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.041 · Cited by 82
Self-citationBurrack, K. S., & Morrison, T. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00428 · Cited by 76
“They further showed that CD8 T cells from chronic HBV patients, regardless of their antigen specificity, exhibited less IL-2 but not IFN-γ or TNF-α production and impaired proliferation following TCR-dependent stimulation, indicating an aberrant antiviral T cell response in chronic HBV infection (80).”
BackgroundResultInfluentialImmunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection
Zhang, Z., Zhang, J., Wang, L., & Wang, F. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06940.x · Cited by 77
Attenuated effector T cells are linked to control of chronic HBV infection
Heim, K., Sagar, Sogukpinar, Ö., Llewellyn‐Lacey, S., Price, D. A., Emmerich, F., Kraft, A. R. M., Cornberg, M., Kielbassa, S., Knolle, P. A., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01928-4 · Cited by 78
Hepatitis B infection: current concepts and future challenges
Nebbia, G., Peppa, D., & Maini, M. K. (2012) · QJM · doi:10.1093/qjmed/hcr270 · Cited by 72
Self-citationWang, J., Zhao, W., Cheng, L., Guo, M., Li, D., Li, X., Tan, Y. J., Ma, S., Li, S., Yang, Y., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000927 · Cited by 70
Natural history of chronic hepatitis B virus infection.
Busch, K., & Thimme, R. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0369-7 · Cited by 68
“Besides, deprivation of the essential amino acid l-arginine, caused by dying hepatocytes releasing arginase, impairs T-cell receptor signaling due to the down-regulation of the CD3ζ-chain on T cells [72, 73].”
BackgroundLocal Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia
Abebe, T., Hailu, A., Woldeyes, M., Mekonen, W., Bilcha, K. D., Cloke, T., Fry, L., al Basatena, N.-K. S., Corware, K., Modolell, M., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001684 · Cited by 72
“The downregulation of T cell responses by arginase-induced L-arginine depletion has been studied in several cancer models [25], in corneal transplantation [27] and pregnancy [28] and increased arginase activities have been associated with a variety of infectious diseases such as schistosomiasis [29], trypanosomiasis […”
BackgroundWang, F., & Zhang, Z. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.50 · Cited by 73
Lempp, F. A., Volz, T., Cameroni, E., Benigni, F., Zhou, J., Rosen, L. E., Noack, J., Zatta, F., Kaiser, H., Bianchi, S., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.003 · Cited by 64
Immune Control of Hepatitis B Virus
Bauer, T., Sprinzl, M. F., & Protzer, U. (2011) · Digestive Diseases · doi:10.1159/000329809 · Cited by 70
“These data indicate a higher selection pressure by HBcAg-specific CD8+ T cells compared to T cell responses against other HBV antigens.Intrahepatic CD8+ T cells seem to be impaired in patients with chronic HBV infection regardless of their specificity [”
ResultImmune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma
Elsegood, C. L., Tirnitz‐Parker, J. E. E., Olynyk, J. K., & Yeoh, G. C. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.47 · Cited by 66
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
Boni, C., Barili, V., Acerbi, G., Rossi, M., Vecchi, A. L., Laccabue, D., Penna, A., Missale, G., Ferrari, C. I., & Fisicaro, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112754 · Cited by 63
“This finding has been further confirmed by partial CD8 cell functional reconstitution following in vitro arginine replenishment [68].”
Immunopathogenesis of chronic hepatitis B
Балмасова, И. П., Yushchuk, N. D., Mynbaev, O. A., Alla, N. R., Малова, Е. С., Shi, Z., & Gao, C.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14156 · Cited by 70
Zhao, J., Li, Y., Jin, L., Zhang, S., Fan, R., Sun, Y., Zhou, C., Shang, Q., Li, W., Zhang, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049135 · Cited by 64
“During acute HBV infection, virus-specific T cell responses are often readily detectable and multi-specific [5–7]; while in chronic HBV infections, virus-specific T cell responses are generally weak and display functional exhaustion as a result of the upregulation of programmed death-1 [8,9], T cell attrition through…”
BackgroundCheckpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
Hoogeveen, R. C., & Boonstra, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00401 · Cited by 64
Prospects for the Global Elimination of Hepatitis B
Block, T. M., Chang, K., & Guo, J. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-062728 · Cited by 62
Adoptive T-cell therapy for HBV-associated HCC and HBV infection
Tan, A. T., & Schreiber, S. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104748 · Cited by 71
Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
Gill, U. S., Pallett, L. J., Kennedy, P. T. F., & Maini, M. K. (2018) · Gut · doi:10.1136/gutjnl-2017-314873 · Cited by 61
Self-citationPriming and Maintenance of Adaptive Immunity in the Liver
Kawashima, K., Andreata, F., Beccaría, C. G., & Iannacone, M. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-041354 · Cited by 64
Bertoletti, A., & Ferrari, C. I. (2013) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-301073rep · Cited by 61
Self-citationHeterogeneity of HBV-Specific CD8+ T-Cell Failure: Implications for Immunotherapy
Heim, K., Neumann‐Haefelin, C., Thimme, R., & Hofmann, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02240 · Cited by 62
Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?
Bertoletti, A., & Gehring, A. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003784 · Cited by 58
“Furthermore, IL-10 [16], TGF-b [27], arginase [28], and T regulatory cells [29] are increased in the chronically inflamed livers.”
Self-citationTissue‐specific effector functions of innate lymphoid cells
Björkström, N. K., Kekäläinen, E., & Mjösberg, J. (2013) · Immunology · doi:10.1111/imm.12098 · Cited by 58
Zeng, Q., Yang, B., Sun, H., Feng, G., Jin, L., Zou, Z., Zhang, Z., Zhang, J., & Wang, F. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2282 · Cited by 53
“Because CD8 ζ can be downregulated via depletion of Larginine (Das et al., 2008), we investigated whether supplementation with L-arginine had the potential to upregulate TCR ζ expression on CD8 T cells.”
BackgroundMethodInfluentialImmunobiology of hepatitis B virus infection
Isogawa, M., & Tanaka, Y. (2014) · Hepatology Research · doi:10.1111/hepr.12439 · Cited by 58
Innate and Adaptive Immune Responses in Hepatitis B Virus Infection
Das, A., & Maini, M. K. (2010) · Digestive Diseases · doi:10.1159/000282075 · Cited by 56
“In addition to attrition of virus-specific CD8 T cell responses, a functional skewing of non-antigen-specific CD8 T cells has also been described in patients with chronic HBV infection [”
BackgroundSelf-citationTumino, N., Turchi, F., Meschi, S., Lalle, E., Bordoni, V., Casetti, R., Agrati, C., Cimini, E., Montesano, C., Colizzi, V., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000871 · Cited by 50
Adaptive response in hepatitis B virus infection
Loggi, E., Gamal, N., Bihl, F. K., Bernardi, M., & Andreoné, P. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12255 · Cited by 51
Hepatitis B virus large surface protein: function and fame.
Churin, Y., Roderfeld, M., & Roeb, E. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.12.08 · Cited by 55
“After long exposure to high levels of viral antigen in chronic hepatitis B patients, T cells either display an exhausted phenotype (34-37) or are deleted (38,39).”
Backgroundvan Bömmel, F., & Berg, T. (2021) · Hepatology Communications · doi:10.1002/hep4.1708 · Cited by 51
Dai, K., Huang, L., Chen, J., Yang, L., & Gong, Z. (2014) · Immunology · doi:10.1111/imm.12400 · Cited by 45
Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection
Chen, C., Feng, X., Liao, H.-Y., Jin, W.-J., Zhang, J., Wang, Y., Gong, L., Liu, J.-J., Yuan, X., Zhao, B.-B., et al. (2014) · Scientific Reports · doi:10.1038/srep06359 · Cited by 44
T cell metabolism in chronic viral infection
Pallett, L. J., Schmidt, N. M., & Schurich, A. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13308 · Cited by 46
CD8+ T cell tolerance following antigen recognition on hepatocytes
Holz, L. E., Warren, A., Couteur, D. G. L., Bowen, D. G., & Bertolino, P. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.005 · Cited by 48
“This profile was attributable to a lack of arginine in the liver [50].”
Background
Metadata
- Authors
- Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T. F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., Bertoletti, A., Akbar, A. N., & Maini, M. K.
- Affiliations
- 1Division of Infection and Immunity
- Addenbrooke's Hospital (GB)
- 2Institute of Hepatology
- Cell Biotech (South Korea) (KR)
- Agency for Science, Technology and Research (SG)
- University College London (GB)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-08-11
- Volume
- 205
- Issue
- 9
- Pages
- 2111-2124
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2526205
- OpenAlex
- W2020211914
- Cited by
- 256
- References
- 60
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 9 · 2023: 12 · 2022: 9 · 2021: 16 · 2020: 14 · 2019: 16 · 2018: 13 · 2017: 16 · 2016: 11 · 2015: 15 · 2014: 20 · 2013: 19 · 2012: 25
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University College London
- Medical Research Council
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- chronic hepatitis B, CD8+ T cells, T cell dysfunction, T cell receptor signaling, CD3zeta, arginine deprivation, IL-2 production, T cell proliferation, interferon-gamma, TNF-α, liver inflammation, intrahepatic T cells
- MeSH terms
- Adult, Aged, Female, Hepatitis B virus, Humans, Interferon-gamma, Interleukin-2, Male, Middle Aged, Models, Biological, Tumor Necrosis Factor-alpha, HLA-A2 Antigen, CD8-Positive T-Lymphocytes, Viral Load, Hepatitis B, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.